Latest news
Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease - Pharmacy TimesPharmacy Times · Sun, 09 Aug 2026 14:05:20 GMTQ&A: Prepare for FDA Inspection on Compounded GLP-1s - Pharmacy TimesPharmacy Times · Fri, 07 Aug 2026 16:45:10 GMTCVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal - Pharmacy TimesPharmacy Times · Fri, 07 Aug 2026 16:09:33 GMTWhat patients need — and what gets in the way - Pharmacy TimesPharmacy Times · Fri, 07 Aug 2026 13:57:16 GMTAfter 2 CRLs, FDA Approves Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 20:58:22 GMTReal-World Semaglutide Use Linked to Lower Liver Stiffness, With Benefits Beyond Weight Loss - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 20:24:25 GMTThe Impact of Bispecifics in Community Oncology Settings - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 19:59:43 GMTWhy Open Communication Across Specialties Is Critical to Complex SM Care - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 18:48:19 GMT